Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database


Kelestimur F. , Jonsson P., Molvalilar S., Gomez J., Auernhammer C., Colak R., ...Daha Fazla

EUROPEAN JOURNAL OF ENDOCRINOLOGY, cilt.152, ss.581-587, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 152 Konu: 4
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1530/eje.1.01881
  • Dergi Adı: EUROPEAN JOURNAL OF ENDOCRINOLOGY
  • Sayfa Sayıları: ss.581-587

Özet

Objective: Sheehan's syndrome occurs as a result of ischaemic pituitary necrosis due to severe postpartum haemorrhage. It is one of the most important causes of hypopituitarism. and hence growth hormone deficiency (GHD), in developing countries. However, little is known about the effects of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.